Sutro Biopharma Correlations

STRO Stock

USD 2.61 0.10 3.98%

The current 90-days correlation between Sutro Biopharma and Larimar Therapeutics is 0.35 (i.e., Weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sutro Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sutro Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Sutro Biopharma Correlation With Market

Very weak diversification

The correlation between Sutro Biopharma and DJI is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.

Moving together with Sutro Stock

0.8	VALN	Valneva SE ADR	Pair Corr
0.68	IPSC	Century Therapeutics	Pair Corr
0.71	NKTX	Nkarta Inc	Pair Corr
0.61	AGL	agilon health Buyout Trend	Pair Corr
0.76	BACK	IMAC Holdings	Pair Corr
0.77	CYRX	Cryoport	Pair Corr

Moving against Sutro Stock

0.42	KZR	Kezar Life Sciences	Pair Corr
0.33	RNXT	RenovoRx	Pair Corr
0.77	T	ATT Inc Sell-off Trend	Pair Corr
0.7	HD	Home Depot	Pair Corr
0.66	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.6	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.59	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.59	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.56	HPQ	HP Inc	Pair Corr
0.51	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.5	VFS	VinFast Auto Earnings Call Today	Pair Corr
0.5	BAC	Bank of America Aggressive Push	Pair Corr
0.38	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.38	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.33	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr

Related Correlations Analysis

	PCVX	LRMR	SNDX	MRUS	IDYA	ANAB	MGTX	KROS	FIXX	NAMSW
PCVX		-0.07	0.13	0.26	-0.06	0.36	-0.21	0.51	0.13	-0.33	PCVX
LRMR	-0.07		0.58	0.67	0.32	-0.08	0.34	0.2	-0.58	0.29	LRMR
SNDX	0.13	0.58		0.76	0.51	0.37	-0.15	0.02	-0.22	-0.22	SNDX
MRUS	0.26	0.67	0.76		0.34	0.29	0.01	0.28	-0.26	-0.03	MRUS
IDYA	-0.06	0.32	0.51	0.34		0.71	-0.63	-0.61	0.02	-0.55	IDYA
ANAB	0.36	-0.08	0.37	0.29	0.71		-0.78	-0.44	0.46	-0.81	ANAB
MGTX	-0.21	0.34	-0.15	0.01	-0.63	-0.78		0.6	-0.37	0.86	MGTX
KROS	0.51	0.2	0.02	0.28	-0.61	-0.44	0.6		-0.23	0.52	KROS
FIXX	0.13	-0.58	-0.22	-0.26	0.02	0.46	-0.37	-0.23		-0.4	FIXX
NAMSW	-0.33	0.29	-0.22	-0.03	-0.55	-0.81	0.86	0.52	-0.4		NAMSW
	PCVX	LRMR	SNDX	MRUS	IDYA	ANAB	MGTX	KROS	FIXX	NAMSW

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NAMSW	+ 0.86	MGTX
MRUS	+ 0.76	SNDX
ANAB	+ 0.71	IDYA
MRUS	+ 0.67	LRMR
KROS	+ 0.6	MGTX
SNDX	+ 0.58	LRMR

High negative correlations

NAMSW	- 0.81	ANAB
MGTX	- 0.78	ANAB
MGTX	- 0.63	IDYA
KROS	- 0.61	IDYA
FIXX	- 0.58	LRMR
NAMSW	- 0.55	IDYA

Risk-Adjusted Indicators

There is a big difference between Sutro Stock performing well and Sutro Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sutro Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PCVX	2.21	0.43	0.08	(0.32)	2.18	(2.58)	3.32	(4.09)	42.81
LRMR	4.04	(0.43)	0.00	(0.09)	0.00	0.00	10.87	(9.55)	26.71
SNDX	2.32	(0.52)	0.00	(0.09)	0.00	0.00	4.02	(4.33)	34.00
MRUS	1.66	(0.37)	0.00	(0.21)	0.00	0.00	3.08	(2.83)	10.85
IDYA	2.21	(0.75)	0.00	(0.36)	0.00	0.00	4.15	(5.09)	15.21
ANAB	3.40	(0.92)	0.00	(0.17)	0.00	0.00	5.77	(7.28)	35.57
MGTX	2.69	0.47	0.19	0.37	2.47	(3.10)	6.75	(5.68)	21.07
KROS	2.06	0.19	0.10	0.26	2.13	(2.28)	4.39	(4.31)	16.94
FIXX	2.82	0.01	0.01	0.13	3.52	(3.25)	5.77	(5.61)	19.43
NAMSW	4.48	0.74	0.09	0.69	6.00	(6.32)	14.04	(8.92)	62.45

Sutro Biopharma Corporate Management

Barbara Leyman	Chief Officer	Profile
Shabbir Anik	Chief Technical Operations Officer	Profile
William JD	CEO Director	Profile
Nicki Vasquez	Chief Officer	Profile
Annie MBA	VP Relations	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC